Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
Hoffmann-La Roche
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Alentis Therapeutics AG
Merck Sharp & Dohme LLC
Neonc Technologies, Inc.
Terremoto Biosciences Inc.
Merus B.V.
Servier
Merck Sharp & Dohme LLC
Tang-Du Hospital
Radiopharm Theranostics, Ltd